MLPs in the VHA help minimize ethical tensions that tend to come up when diagnosing and documenting disability.

Legal advocacy addresses patients’ health-harming legal needs in housing, public benefits, employment, education, immigration, domestic violence, and other areas of law.

Clinicians caring for patients with OUD should plan for possible disruptions of treatment caused by arrests and pretrial confinements.

Evidence of harm reduction interventions’ morbidity and mortality benefits is abundant and of high quality.

Severe withdrawal, risk of patient-initiated discharge, and some inpatients’ uses of substances prompt questions considered in this commentary.

Some clinicians might neglect discussing benefits and harms of antimicrobials with their patients during advance care planning processes.

This commentary on a case describes need for clinician collaboration to optimize therapeutic use of antimicrobials in clinical settings.

Many marginalized patients with disabilities reside in nursing homes and are more susceptible to antibiotic under- and overtreatment.

Patients living in low-and middle-income countries (LMICs) shoulder the greatest burden of infections caused by antimicrobial-resistant pathogens.

This article discusses fiduciary obligations transplant programs might have to patients with B cenocepacia.